Cargando…

Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer

PURPOSE: Current clinical prognostic factors are not accurate enough to identify and monitor those muscle-invasive bladder cancer (MIBC) patients at high risk of progression after radical cystectomy (RC). Here, we determined genetic alterations in the tumor and circulating tumor cell (CTC) enumerati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrasco, Raquel, Ingelmo-Torres, Mercedes, Gómez, Ascensión, Roldán, Fiorella L., Segura, Natalia, Ribal, María José, Alcaraz, Antonio, Izquierdo, Laura, Mengual, Lourdes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203260/ https://www.ncbi.nlm.nih.gov/pubmed/35713686 http://dx.doi.org/10.1007/s00345-022-04061-9

Ejemplares similares

Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer
por: Carrasco, Raquel, et al.
Publicado: (2022)

Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication
por: Carrasco, Raquel, et al.
Publicado: (2021)

Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer
por: Ingelmo-Torres, Mercedes, et al.
Publicado: (2017)

Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2022)

Prognostic value of circulating microRNAs in upper tract urinary carcinoma
por: Montalbo, Ruth, et al.
Publicado: (2018)

Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2021)

Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers
por: Mengual, Lourdes, et al.
Publicado: (2016)

Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays
por: Mengual, Lourdes, et al.
Publicado: (2008)

Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study
por: Izquierdo, Laura, et al.
Publicado: (2017)

Urine cell-based DNA methylation classifier for monitoring bladder cancer
por: van der Heijden, Antoine G., et al.
Publicado: (2018)

Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer Patients
por: Rampazzo, Enrica, et al.
Publicado: (2020)

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2014)

Validation of Urine-based Gene Classifiers for Detecting Bladder Cancer in a Chinese Study
por: Han, Chengtao, et al.
Publicado: (2018)

Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection
por: Miyake, Makito, et al.
Publicado: (2013)

TERT Core Promotor Mutations in Early-Onset Bladder Cancer
por: Giedl, Johannes, et al.
Publicado: (2016)

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
por: Zvereva, Maria, et al.
Publicado: (2020)

TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers
por: Weyerer, Veronika, et al.
Publicado: (2021)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer
por: Wan, Song, et al.
Publicado: (2021)

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer
por: Agarwal, Neeraj, et al.
Publicado: (2022)

Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2020)

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
por: Lee, Yujin, et al.
Publicado: (2017)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer
por: Li, Chong, et al.
Publicado: (2015)

Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancer
por: Iemura, Yusuke, et al.
Publicado: (2023)

Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis
por: Jiang, Hui, et al.
Publicado: (2021)

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
por: Tunthanathip, Thara, et al.
Publicado: (2021)

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
por: Tan, Melissa P., et al.
Publicado: (2018)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer
por: Leão, Ricardo, et al.
Publicado: (2018)

Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
por: Descotes, Françoise, et al.
Publicado: (2017)

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
por: Batista, Rui, et al.
Publicado: (2020)

MNS16A VNTR polymorphic sequence variations of the TERT gene and bladder cancer: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016)

Effect of Parameters on Oxychlorination of Tert-Butyl Ethers
por: Gaca, Jerzy, et al.
Publicado: (2008)

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis
por: van Poppelen, Natasha M., et al.
Publicado: (2021)

PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power
por: Poos, Alexandra M., et al.
Publicado: (2022)

(R)-N-{2-tert-Butyl-2-[(R)-tert-butylsulfonamido]ethylidene}-tert-butanesulfonamide
por: Hu, Yu, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hpplak3ki1jo8bfmmputvq1ghg